Today’s $1B AED market consists of institutional buyers, including emergency healthcare professionals, and “public access” venues such as airports, stadiums, shopping malls, etc. These commercial AEDs cost $1,500 to over $2,500, and there is no device with embedded wireless capabilities. Tricord addresses this market through its Tricord Labs AED products with performance and price leadership delivering breakthrough portability, full 360 joule operation, and unique intelligence for proven safety and efficacy.
80% of SCA occurs in the home striking down over age 55 at risk consumers while family members or friends witnessing the attack stand by helplessly hoping that a 911 call results in timely delivery of an AED. Currently in the US 26 million over 55 seniors, many with cardiac issues and co-morbidities that place them at high risk for SCA live with a family member or friend who can assist them in the event of an SCA attack. The Tricord Labs Personal AED products provide a new solution set for these at risk consumers which will dramatically affect our ability to prevent Sudden Cardiac Arrest.